Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 5;23(1):579.
doi: 10.1186/s12879-023-08563-8.

Klebsiella pneumoniae bacteraemia epidemiology: resistance profiles and clinical outcome of King Fahad Medical City isolates, Riyadh, Saudi Arabia

Affiliations

Klebsiella pneumoniae bacteraemia epidemiology: resistance profiles and clinical outcome of King Fahad Medical City isolates, Riyadh, Saudi Arabia

Taghreed A Hafiz et al. BMC Infect Dis. .

Abstract

Background and objectives: Klebsiella pneumoniae (K. pneumoniae) is the second leading cause of community-acquired and hospital-acquired gram-negative bloodstream infection (BSI). This study aimed to assess the epidemiological and microbial-resistance characteristics and clinical factors associated with K. pneumoniae BSI in Saudi Arabia.

Materials and methods: Data of 152 K. pneumoniae isolates diagnosed between January 2019 and January 2020 at King Fahad Medical City, Riyadh, Saudi Arabia were evaluated retrospectively. Clinical records of the patients were collected and analysed statistically.

Results: In total, 152 cases of K. pneumoniae BSI were identified. Adult patients (66.4%) were at a higher risk of developing the infection than paediatric patients (33.6%). The rate of infection was slightly higher in women than in men. Neurological disorders were the predominant underlying conditions for the acquisition of K. pneumoniae BSI, at all ages. Most of the deceased patients were adults with multi-organ dysfunction. Klebsiella pneumoniae showed disturbing resistance to amoxicillin-clavulanate and cefuroxime (72.4%), ceftazidime (67.8), cephalothin (76.3%), and to Carbapenems (36.1%).

Conclusions: The impact of K. pneumoniae BSI was seen not only at the patient level, but also at the community level, and was related to multi-drug resistant infection. These findings provide a better understanding of microbial resistance and its association with patient clinical outcomes.

Keywords: Bacteraemia; Klebsiella pneumoniae; Multi-drug resistant; Nosocomial infection; Pan-drug resistant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Antibiotic susceptibility of Klebsiella pneumoniae bloodstream isolates (n = 152). AMP, ampicillin; AMC, amoxicillin-clavulanate; AMK, amikacin; CEF, cephalothin; COL, colistin; CTZ, ceftazidime; CXM, cefuroxime; CFPM, cefepime; CTX, cefotaxime; CRO, ceftriaxone; CIP, ciprofloxacin; ETP, ertapenem; FOX, cefoxitin; GM, gentamicin; IPM, imipenem; LVX, levofloxacin; MER, meropenem; TGC, tigecycline; TMP-SMX, trimethoprim-sulfamethoxazole; TZP, piperacillin-tazobactam

References

    1. Bagley ST. Habitat association of Klebsiella species. Infect Control. 1985;6. 10.1017/S0195941700062603. no. 2. - PubMed
    1. Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4). 10.1128/cmr.11.4.589. - PMC - PubMed
    1. Montgomerie JZ, Ota JK. “Klebsiella Bacteremia Forty-one patients with Klebsiella bacteremia admitted.” [Online]. Available: http://archinte.jamanetwork.com/.
    1. Ko WC, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis. 2002;8(2). 10.3201/eid0802.010025. - PMC - PubMed
    1. Tsay RW, Siu LK, Fung CP, Chang FY. Characteristics of bacteremia between community-acquired and nosocomial Klebsiella pneumoniae infection: risk factor for mortality and the impact of capsular serotypes as a herald for community-acquired infection. Arch Intern Med. 2002;162(9). 10.1001/archinte.162.9.1021. - PubMed

MeSH terms

Substances

LinkOut - more resources